肾小管细胞TIF1γ缺陷加重肾损伤诱导的多倍体与纤维化
该研究探讨转录中介因子1γ(TIF1γ)在肾小管间质纤维化中的作用。发现CKD患者及实验性肾纤维化小鼠肾小管TIF1γ表达降低;小鼠肾小管特异性敲除TIF1γ加重UUO和FAN诱导的肾小管细胞多倍体化和后续纤维化,而过表达肾脏TIF1γ可保护小鼠免于肾纤维化。机制上,TIF1γ通过抑制TGF-β信号和泛素化EGFR促进其内吞降解来发挥抗纤维化作用;药理抑制EGFR信号可减轻TIF1γ敲除小鼠加重的多倍体化和纤维化表型。
要点
- CKD患者及实验性肾纤维化小鼠肾小管TIF1γ表达降低。
- 肾小管特异性敲除TIF1γ加重UUO和FAN诱导的多倍体化及纤维化。
- TIF1γ通过抑制TGF-β信号及泛素化EGFR促进其降解发挥抗纤维化作用。
核心结论
- 肾小管TIF1γ通过抑制促纤维化EGFR和TGF-β信号在肾纤维化中发挥重要作用。
- 维持肾小管TIF1γ稳态可能是治疗肾小管间质纤维化及后续CKD的新治疗选择。
研究设计与样本
- 研究检测了CKD患者(包括糖尿病、高血压和IgA肾病)及小鼠实验性肾纤维化模型(UUO、FAN和马兜铃酸诱导肾毒性)中肾小管TIF1γ表达。
- 使用肾小管特异性TIF1γ敲除小鼠和肾脏TIF1γ过表达小鼠,在UUO和FAN模型中观察多倍体化和纤维化。
- 在肾小管上皮细胞中探讨TIF1γ通过TGF-β依赖和非依赖信号发挥抗纤维化作用的机制。
主要发现
- TIF1γ在肾脏近端小管的细胞质和细胞核中高表达。
- CKD患者及实验性肾纤维化小鼠(UUO、FAN和马兜铃酸肾病)肾小管TIF1γ表达降低。
- 肾小管特异性敲除TIF1γ加重UUO和FAN诱导的肾小管细胞多倍体化和后续纤维化,而肾脏TIF1γ过表达保护小鼠免于肾纤维化。
- TIF1γ通过抑制肾小管细胞中转录因子Smad复合物的形成和活性直接阻碍TGF-β信号。
- TIF1γ在肾小管细胞中通过泛素化EGFR的赖氨酸851/905位点促进EGFR内化和溶酶体降解,从而抑制TGF-β信号上游的EGFR信号。
临床怎么用
- 维持肾小管TIF1γ稳态可能成为治疗肾小管间质纤维化及后续CKD的新治疗选择。
- 药理抑制EGFR信号可能减轻TIF1γ缺陷加重的多倍体化和纤维化表型。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tubulointerstitial fibrosis is considered the final convergent pathway of progressive chronic kidney diseases (CKD) regardless of etiology. However, mechanisms underlying kidney injury-induced fibrosis largely remain unknown. Recent studies have indicated that transcriptional intermediary factor 1γ (TIF1γ) inhibits the progression of fibrosis in other organs. Here, we found that TIF1γ was highly expressed in the cytoplasm and nucleus of the kidney proximal tubule. Interestingly, we found tubular TIF1γ expression was decreased in patients with CKD, including those with diabetes, hypertension, and IgA nephropathy, and in mouse models with experimental kidney fibrosis (unilateral ureteral obstruction [UUO], folic acid nephropathy [FAN], and aristolochic acid-induced nephrotoxicity). Tubule-specific knock out of TIF1γ in mice exacerbated UUO- and FAN-induced tubular cell polyploidy and subsequent fibrosis, whereas overexpression of kidney TIF1γ protected mice against kidney fibrosis. Mechanistically, in tubular epithelial cells, TIF1γ exerted an antifibrotic role via transforming growth factor-β (TGF-β)-dependent and -independent signaling. TIF1γ hindered TGF-β signaling directly by inhibiting the formation and activity of the transcription factor Smad complex in tubular cells, and we discovered that TIF1γ suppressed epidermal growth factor receptor (EGFR) signaling upstream of TGF-β signaling in tubular cells by ubiquitylating EGFR at its lysine 851/905 sites thereby promoting EGFR internalization and lysosomal degradation. Pharmacological inhibition of EGFR signaling attenuated exacerbated polyploidization and the fibrotic phenotype in mice with tubule deletion of TIF1γ. Thus, tubular TIF1γ plays an important role in kidney fibrosis by suppressing profibrotic EGFR and TGF-β signaling. Hence, our findings suggest that maintaining homeostasis of tubular TIF1γ may be a new therapeutic option for treating tubulointerstitial fibrosis and subsequent CKD.
引用
- Yuan C, Jin G, Li P, et al. Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis. Kidney Int. 2023. PMID: 37482091. doi:10.1016/j.kint.2023.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。